Biological and Genetic Aspects of Obesity

Introduction

Obesity is a complex, multifactorial condition influenced by genetic, biological, and environmental factors. Understanding the mechanisms underlying obesity is essential for effective management and treatment. This guide summarizes the genetic basis of obesity, its classification, staging, and current therapeutic approaches.

Adipose Tissue and Obesity

Types and Distribution of Adipose Tissue

• White adipose tissue is the most abundant type in the human body, distributed into subcutaneous (under the skin) and visceral (around organs) compartments.

• Adipose tissue can undergo remodeling through hypertrophy (increase in cell size) or hyperplasia (increase in cell number).

Pathophysiology of Adipose Tissue in Obesity

• Hypertrophy of adipocytes leads to altered production of adipokines (signaling proteins), promoting inflammation, insulin resistance, and vascular changes.

• Ectopic fat deposits (fat stored in non-adipose tissues) cause local cell dysfunction, impaired metabolism, and cell death, compounding health risks.

• Obesity is associated with increased volume in other organs and tissues, diversifying health risks.

Genetics of Obesity

Definition and Heritability

• Genetics is the branch of biology concerned with the study of genes, genetic variation, and heredity in organisms.

• Body weight is highly heritable: up to 70% of variation in body weight between individuals may be due to genetic makeup.

• Studies in twins show that the body weight of monozygotic twins (identical) is more concordant than that of dizygotic twins (fraternal), even when raised apart, indicating a strong genetic component.

Genes and Alleles

• A gene is the basic physical and functional unit of heredity, composed of DNA and providing instructions for making proteins.

• Humans have over 20,000 genes, with two copies of each gene (one from each parent).

• Small differences in the same gene are called alleles, and differences in less than 1% of our genes contribute to individual features.

Obesity Susceptibility Genes

• Identification of genes that confer obesity susceptibility provides insight into mechanisms of weight regulation and fat distribution.

• These findings are leveraged to develop approaches for treatment and prevention.

Monogenic Forms of Obesity

Definition and Characteristics

• Monogenic obesity results from a mutation in a single gene and is rare.

• Typically characterized by early-onset obesity (beginning shortly after birth), a predominantly hyperphagic (excessive eating) condition, constant hunger, lack of satiety, food-seeking behavior, and increased food consumption.

Examples of Monogenic Obesity

Polygenic Mechanisms of Obesity

Definition and Genetic Architecture

• Most obesity is polygenic, resulting from the interaction of many genes (each with small effects) and environmental factors.

• Variants with small effects on body weight are called common variants.

• Genome-wide association studies (GWAS) have identified over 300 loci associated with obesity, but each accounts for a small proportion of risk.

• Single-nucleotide polymorphisms (SNPs) are the most common type of genetic variation, involving the substitution of a single nucleotide at a specific position in the genome.

Example: FTO Gene

• The FTO gene is associated with increased risk of obesity by 1.20–1.32-fold and an increase in BMI by approximately 0.37 kg/m2.

Staging and Management of Obesity

Obesity Staging Criteria

Staging of obesity provides a framework for managing patients based on the presence of comorbidities, mental health, and functional status.

Treatment of Obesity

Lifestyle Intervention

• First-line therapy for obesity includes low-risk approaches aimed at promoting weight loss.

• Effective lifestyle therapy includes three components:

  • Dietary modification

  • Increased physical activity

  • Behavioral change

Pharmacotherapy

• Indicated as an adjunct to diet, exercise, and behavioral therapy.

• Medications target various mechanisms to alter energy balance, such as:

  • Interfering with nutrient absorption (e.g., Orlistat)

  • Delaying gastric emptying (e.g., Liraglutide)

  • Modulating neurotransmitter actions in appetite circuits (e.g., Naltrexone-bupropion, Phentermine-topiramate)

• Additional medications may be used to address comorbidities (e.g., insulin sensitizers for glucose intolerance, statins for hyperlipidemia, antihypertensives, antidepressants, analgesics).

Bariatric Surgery

• Involves anatomical manipulations that restrict stomach size and/or interfere with nutrient absorption.

• Highly effective for inducing weight loss and improving cardiometabolic comorbidities.

• Requires adaptation to dietary changes, vitamin and mineral replacement, and monitoring for complications (e.g., dumping syndrome, reflux, hypoglycemia).

• Long-term data support reduction in obesity-related all-cause mortality.

Key Take-Home Messages

• Genetic factors explain much of the variation in body weight across individuals.

• Monogenic forms of obesity are rare and typically result from mutations in genes involved in energy balance.

• Common obesity is polygenic, with over 300 loci identified, each contributing a small effect.

• Staging of obesity enables a tailored approach to management, considering comorbidities, mental health, and functional status.

• Lifestyle interventions are first-line; pharmacotherapy and surgery are adjuncts for selected patients.